feed,title,long_url,short_url
Benzinga,"Barclays Upgrades Cirrus Logic To Overweight, Increased PT Implies 20% Upside",https://benzinga.com/analyst-ratings/analyst-color/21/09/22823015/barclays-upgrades-cirrus-logic-to-overweight-increased-pt-implies-20-upside,https://j.mp/3kZR8tF
Benzinga,Statera BioPharma: The Ticker Formerly Known as CBLI,https://benzinga.com/general/biotech/21/09/22823621/statera-biopharma-the-ticker-formerly-known-as-cbli,https://j.mp/3jQc33e
